Immediate Pelvic Imaging to Rule Out Androgen-Secreting Ovarian Tumor
In this 60-year-old postmenopausal woman with markedly elevated progesterone (5.15) and estradiol (218), you must immediately obtain transvaginal ultrasound and consider pelvic CT/MRI to exclude an androgen-secreting ovarian tumor, particularly a Leydig cell tumor or other sex cord-stromal neoplasm.
Clinical Context and Red Flags
This hormonal profile is highly abnormal for a postmenopausal woman and raises immediate concern for neoplastic pathology:
- Elevated estradiol (218): Normal postmenopausal estradiol should be <30 pg/mL. This 7-fold elevation suggests active hormone production
- Elevated progesterone (5.15): Postmenopausal women should have progesterone <1 ng/mL. This elevation is particularly concerning
- Testosterone (1.4): While this appears within normal range, the context of elevated estradiol and progesterone suggests possible aromatization from an androgen-secreting tumor
The combination of elevated sex steroids in a postmenopausal woman is a red flag for ovarian neoplasm, even without overt virilization symptoms 1, 2, 3.
Algorithmic Diagnostic Approach
Step 1: Immediate Imaging
- Transvaginal ultrasound (first-line): Can detect ovarian masses as small as 6mm 2
- Pelvic CT or MRI: If ultrasound is negative or equivocal, proceed to cross-sectional imaging 1
- Abdominal CT: To evaluate adrenal glands, though normal testosterone makes adrenal source less likely
Step 2: Additional Biochemical Testing
While imaging is being arranged, obtain:
- Inhibin A and B: Elevated levels strongly suggest ovarian sex cord-stromal tumors and can help localize the source 3
- DHEA-S: Normal levels favor ovarian over adrenal source
- Repeat testosterone: Document any progression
- LH and FSH: Suppressed gonadotropins with elevated sex steroids confirm autonomous hormone production 3
Step 3: Clinical Assessment
Document presence or absence of:
- Rapid-onset hirsutism (face, trunk, areolae)
- Voice deepening
- Clitoromegaly
- Temporal balding
- Acne
Rapid onset of virilization (over 6-9 months) is particularly concerning for malignancy 1, 2.
Rationale for Urgency
Ovarian Leydig cell tumors and other sex cord-stromal neoplasms can be small (6-19mm) yet produce massive amounts of androgens and their metabolites 1, 2. These tumors:
- May not cause obvious virilization initially
- Can be missed on imaging if not specifically sought
- Require surgical excision as definitive treatment
- Can occasionally be malignant (e.g., sertoliform endometrioid carcinoma) 3
The elevated progesterone is particularly unusual and may represent either direct tumor secretion or peripheral conversion of androgens.
Common Pitfalls to Avoid
Don't assume PCOS: While polycystic ovary syndrome is the most common cause of hyperandrogenism, it doesn't explain markedly elevated progesterone in a 60-year-old 1
Don't wait for virilization: Tumors can be present without obvious clinical signs initially 2
Don't rely solely on testosterone levels: The testosterone of 1.4 ng/mL may seem borderline, but in context of elevated estradiol and progesterone, this represents significant pathology. Some tumors primarily produce precursors that convert peripherally 3
Don't miss small tumors: Leydig cell tumors can be as small as 6mm and still cause significant hormonal disturbance 2
If Imaging is Negative
If initial imaging is negative but biochemistry remains concerning:
- Consider cetrorelix suppression test (GnRH antagonist): Suppression of testosterone confirms ovarian source even when imaging is negative 2
- Repeat imaging in 3-6 months with dedicated ovarian protocol
- Consider selective venous sampling (rarely needed)
Definitive Management
Bilateral salpingo-oophorectomy is the definitive treatment if an ovarian tumor is identified 1, 2, 3. For patients who cannot undergo surgery, GnRH agonists may provide temporary control 1.